Cisapride in the treatment of visual hallucinations caused by vision loss: the Charles Bonnet syndrome

Am J Geriatr Psychiatry. 1999 Summer;7(3):264-6. doi: 10.1097/00019442-199908000-00012.


The authors describe the use of cisapride (Propulsid), a potent 5-HT(3) antagonist, in the treatment of visual hallucinations in two patients with vision loss (the Charles Bonnet syndrome).

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Cisapride / therapeutic use*
  • Female
  • Hallucinations / drug therapy*
  • Hallucinations / etiology
  • Humans
  • Male
  • Serotonin Receptor Agonists / therapeutic use*
  • Syndrome
  • Vision, Low / complications*
  • Visual Perception


  • Serotonin Receptor Agonists
  • Cisapride